Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference being held at the New York Marriott Marquis in New York, NY. Management will participate in a fireside chat on Tuesday, September 15, 2026, at 1:05 pm Eastern Time and will also participate in one-on-one investor meetings.
Covered in this story
What has happened since
- Erasca Inc is down 13.8% since this was published, 44 days ago.
- Marriott International is up 20.7% since this was published, 44 days ago.
- Morgan Stanley is down 14.9% since this was published, 44 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ERAS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Erasca Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.